NCT06653101View on ClinicalTrials.gov

Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

October 20, 2024

Primary Completion Date

December 5, 2024

Study Completion Date

March 20, 2025

Conditions
Overweight or Obesity
Interventions
DIETARY_SUPPLEMENT

Probiotic

The trial phase of this study lasted 8 weeks, and each patient will make 3 visits (week 0, week 4, week 8)

DIETARY_SUPPLEMENT

Placebo

The trial phase of this study lasted 8 weeks, and each patient will make 3 visits (week 0, week 4, week 8)

Trial Locations (1)

210095

Fei Xu, Zhengzhou

All Listed Sponsors
lead

Wecare Probiotics Co., Ltd.

INDUSTRY

NCT06653101 - Effect of Akkermansia Muciniphila Akk11 on Metabolic and Gut Health in Overweight and Obese Subjects | Biotech Hunter | Biotech Hunter